vancomycin has been researched along with Colitis in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (43.06) | 18.7374 |
1990's | 5 (6.94) | 18.2507 |
2000's | 8 (11.11) | 29.6817 |
2010's | 21 (29.17) | 24.3611 |
2020's | 7 (9.72) | 2.80 |
Authors | Studies |
---|---|
Ariki, S; Chalalai, T; Dewayani, A; Fujitsuka, N; Fukuda, C; Hidano, S; Ishizawa, S; Ito, K; Kamiyama, N; Kobayashi, T; Kubota, K; Kudo, Y; Minata, M; Mizukami, K; Mogami, S; Murakami, K; Nishiyama, M; Ozaka, S; Ozaki, T; Sachi, N; Soga, Y; Sonoda, A | 1 |
Beneš, J; Kohout, P; Krůtová, M; Musil, V; Stebel, R; Vejmelka, J | 1 |
Hasan, N; Yang, H | 1 |
Flannigan, KL; Greenway, SC; Hirota, SA; Lewis, IA; Mohamud, A; Rahim, H; Taylor, MR | 1 |
Andersen, M; Lei, DK; Ollech, JE; Rubin, DT; Sossenheimer, P; Weisshof, R; Zmeter, N | 1 |
Boggiano, VL; Smith, KL; Sullivan, MH | 1 |
Cai, W; Chen, Y; Du, X; Gong, Z; Jin, C; Liu, Y; Tian, C; Wang, L; Wu, J; Xu, C; Zhang, X; Zhu, F | 1 |
Burrello, C; Caprioli, F; Facciotti, F; Giuffrè, MR; Lattanzi, G; Pujolassos, M; Strati, F; Troisi, J | 1 |
Aardema, ND; Benninghoff, AD; Hintze, KJ; Rodriguez, DM; Van Wettere, AJ | 1 |
Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP | 1 |
Chen, L; Davis, MM; Wang, F; Yin, Q | 1 |
Balouch, F; Lewindon, PJ; Muir, R; Reilly, CR; Steward-Harrison, LC; Tan, LZ | 1 |
Corr, SC; De Souza, DP; de Zoete, MR; Flavell, RA; Gerlic, M; Harapas, CR; Kanojia, K; Kile, BT; Kim, ML; Kouremenos, KA; Masters, SL; McConville, MJ; Mielke, LA; Ogura, Y; Papenfuss, AT; Penington, JS; Preaudet, A; Putoczki, TL; Radford-Smith, GL; Simms, LA; Souza-Fonseca-Guimaraes, F; Tye, H; Wilcox, SA; Wockner, LF; Yu, CH; Zakrzewski, M | 1 |
Eiferman, DS; Evans, DC; Feeney, ME; Gerlach, AT; Murphy, CV; Rushing, A; Thompson, M | 1 |
Banovic, T; Hissaria, P; Kette, F; Krummenacher, M; Smith, W | 1 |
Hagel, S; Stallmach, A; Weber, M | 1 |
Nakanishi, Y; Ohteki, T; Sato, T | 1 |
Bell, S; Buxey, KN; Sia, C; Wale, R; Warrier, SK; Wein, D | 1 |
Liu, W; Lv, Z; Peng, G; Su, J; Xu, H | 1 |
Avachat, AM; Shinde, AS | 1 |
Isobe, K; Ito, S; Tanaka, Y | 1 |
Cai, C; Jin, S; Ran, Z; Shen, J; Song, D; Zhao, D; Zheng, Q | 1 |
Akbari, M; Alonso, CD; Castillo, N; Kelly, CP; Leffler, DA; Patel, I; Theethira, T; Villafuerte-Galvez, J; Wungjiranirun, M | 1 |
Ananthakrishnan, AN | 1 |
Baidoo, L; Clarke, K | 1 |
Baban, TA; El-Herte, RI; Kanj, SS | 1 |
de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K | 1 |
Al-Banna, NA; Cerny, V; Gründling, M; Hung, O; Issekutz, TB; Johnston, B; Kelly, M; Kern, H; Lehmann, Ch; Pavlovic, D; Whynot, S; Zhou, J | 1 |
Apisarnthanarak, A; Mundy, LM; Razavi, B | 1 |
Wood, WA | 1 |
McFarland, LV | 1 |
Claesson, MH; Gad, M; Kristensen, NN; Møller, PL; Paerregaard, A | 1 |
Ellis, R; McPherson, S; Panter, SJ; Rees, CJ; Soo, S | 1 |
Alpert, MA; Aradhyula, S; Bhutto, SS; Hafidh, SA; Manian, FA | 1 |
Funada, H; Hattori, K; Ishizaki, T; Kuroda, T; Nakamura, S | 1 |
Gebhard, RL; Gerding, DN; Lee, JT; Olson, MM; Peterson, LR; Schwartz, MJ; Teasley, DG | 1 |
Lamont, JT; Trnka, YM | 1 |
Bartlett, JG | 1 |
Koornhof, HJ; Miller, SD | 1 |
Dudley, MN; Gontarz, N; Nightingale, CH; Quintiliani, R | 1 |
Roberts, R; Seneviratne, E; Stafford, R; Walters, BA | 1 |
Cudmore, MA; Fekety, R; Kim, KH; Liepman, MK; Silva, J | 1 |
Lamont, JT; Levine, HG | 1 |
Thompson, RL; Wenzel, RP | 1 |
Fekety, R; Kim, KH; Silva, J; Toshniwal, R | 1 |
George, WL | 2 |
Baird, I; Batts, DH; Fekety, R; Plouffe, JF; Rifkin, GD; Silva, J | 1 |
Delmée, M; Melin, P; Peetermans, W; Verbist, L; Verschraegen, G | 1 |
Bergeron, L; Boucher, FD | 1 |
Gerding, DN | 1 |
Dieleman, LA; Freitag, R; Li, F; Linde, HJ; Rath, HC; Sartor, RB; Schölmerich, J; Schultz, M | 1 |
Andoh, A; Araki, Y; Bamba, T; Fujiyama, Y; Fukuda, M; Fukuoka, M; Kanauchi, O; Matsumoto, Y; Mitsuyama, K; Sata, M; Takagi, K; Toyonaga, A | 1 |
Cantey, JR; Condon, CW; Humphrey, CD; Pittman, FE | 1 |
Bartlett, JG; Lowe, BR; Onderdonk, AB | 1 |
Burdon, DW; Keighley, M; Mogg, GA | 1 |
Broitman, SA; Katz, L; LaMont, JT; Rieth, S; Rothman, SW; Sonnenblick, EB; Trier, JS | 1 |
Rukhlina, AA | 1 |
Chiou, CY; Chiou, HL | 1 |
Barbezat, GO; Cooper, BT; Lee, DK | 1 |
Buggy, B; Deery, HG; Fekety, R; Kauffman, C; Silva, J | 1 |
Panichi, G | 1 |
Briceland, LL; Nightingale, CH; Quintiliani, R | 1 |
Hopper, JL; Young, GP | 1 |
Bayley, N; McDonald, MI; St John, DJ; Ward, P; Young, GP | 1 |
Buggy, BP; Fekety, R; Silva, J | 1 |
Abraham, PA; Collins, AJ; Halstenson, CE; Matzke, GR; Olson, PL | 1 |
Höchter, W; Ottenjann, R; Wörmann, B | 1 |
Church, JM; Fazio, VW | 1 |
McDonald, M; Young, G | 1 |
12 review(s) available for vancomycin and Colitis
Article | Year |
---|---|
[Gastrointestinal infections].
Topics: Adult; Anti-Bacterial Agents; Clostridium Infections; Colitis; Diagnosis, Differential; Female; Humans; Prednisone; Treatment Outcome; Vancomycin | 2014 |
Clostridium difficile infection: epidemiology, risk factors and management.
Topics: Clostridioides difficile; Colitis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prevalence; Risk Factors; Vancomycin | 2011 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2013 |
Impact of antibiotics on the microcirculation in local and systemic inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Autophagy; Chemotaxis, Leukocyte; Colitis; Cytokines; Humans; Immune System; Inflammation; Metronidazole; Microcirculation; Phagocytosis; Vancomycin | 2013 |
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colitis; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Radiography; Risk Factors; Treatment Outcome; Vancomycin | 2002 |
Alternative treatments for Clostridium difficile disease: what really works?
Topics: Anti-Infective Agents; Carrier State; Clostridioides difficile; Clostridium Infections; Colitis; Complementary Therapies; Cross Infection; Humans; Metronidazole; Vancomycin | 2005 |
Clostridium difficile colitis.
Topics: Adult; Animals; Anti-Bacterial Agents; Carrier State; Child; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Cricetinae; Crohn Disease; Cross Infection; Cytotoxins; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Infant; Infant, Newborn; Vancomycin | 1984 |
Antibiotic-associated colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin | 1984 |
Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function.
Topics: Administration, Oral; Colitis; Drug Eruptions; Edema; Erythema; Humans; Infant; Intestinal Absorption; Kidney; Male; Neutropenia; Syndrome; Vancomycin | 1994 |
Treatment of Clostridium difficile-associated diarrhea and colitis.
Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2000 |
[Drug-induced colitis].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bone Marrow Transplantation; Cholestyramine Resin; Cimetidine; Colitis; Contraceptives, Oral, Hormonal; Enema; Ergotamine; Flucytosine; Gold; Graft vs Host Reaction; Humans; Hydrogen Peroxide; Methyldopa; Metronidazole; Ranitidine; Suppositories; Vancomycin; Vasopressins | 1985 |
4 trial(s) available for vancomycin and Colitis
Article | Year |
---|---|
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
Topics: Adult; Aged; Clinical Trials as Topic; Clostridium Infections; Colitis; Costs and Cost Analysis; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation; Vancomycin | 1983 |
Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium; Clostridium Infections; Colitis; Diarrhea; Humans; Infant; Middle Aged; Vancomycin | 1989 |
A random walk model for evaluating clinical trials involving serial observations.
Topics: Algorithms; Bacitracin; Clinical Trials as Topic; Colitis; Computer Simulation; Double-Blind Method; Esophagitis, Peptic; Humans; Models, Theoretical; Probability; Random Allocation; Time Factors; Vancomycin | 1988 |
Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors.
Topics: Aged; Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colitis; Feces; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Recurrence; Risk; Vancomycin | 1986 |
56 other study(ies) available for vancomycin and Colitis
Article | Year |
---|---|
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Colitis; Colitis, Ulcerative; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Herbal Medicine; Inflammation; Intestinal Mucosa; Japan; Mice; Mice, Inbred C57BL; Vancomycin | 2022 |
[Updated Czech guidelines for the treatment of patients with colitis due to Clostridioides difficile].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Colitis; Czech Republic; Fidaxomicin; Humans; Tigecycline; Vancomycin | 2022 |
Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models.
Topics: Animals; Capsules; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Mice; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha; Vancomycin | 2023 |
Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity.
Topics: Animals; Bacteria; Bacterial Proteins; Body Weight; Colitis; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucuronidase; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mycophenolic Acid; Up-Regulation; Vancomycin | 2019 |
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Duration of Therapy; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Recurrence; Vancomycin; Young Adult | 2019 |
Management of difficult-to-treat
Topics: Administration, Intravenous; Anti-Bacterial Agents; Clostridium Infections; Colitis; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Fecal Microbiota Transplantation; Fidaxomicin; Foot; Humans; Male; Metronidazole; Middle Aged; Osteomyelitis; Vancomycin | 2020 |
Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation.
Topics: Animals; Anti-Bacterial Agents; Colitis; Colon; Cytokines; Deoxycholic Acid; Diet, High-Fat; Feces; Gastrointestinal Microbiome; Gram-Positive Bacteria; Macrophage Activation; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Phosphorylation; Receptor, Muscarinic M2; Toll-Like Receptor 2; Tyrosine; Vancomycin | 2020 |
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Topics: Animals; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Mice; Natural Killer T-Cells; Streptomycin; Th1 Cells; Th17 Cells; Vancomycin | 2021 |
The Western Dietary Pattern Combined with Vancomycin-Mediated Changes to the Gut Microbiome Exacerbates Colitis Severity and Colon Tumorigenesis.
Topics: Animal Feed; Animals; Carcinogenesis; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Diet, Western; Disease Models, Animal; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Vancomycin | 2021 |
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin | 2018 |
Topics: Animals; Antibodies, Neutralizing; Bifidobacterium; Colitis; CTLA-4 Antigen; Mice; Mice, Transgenic; Vancomycin | 2018 |
Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
Topics: Child; Cholangitis, Sclerosing; Colitis; Colitis, Ulcerative; Gastrointestinal Microbiome; Humans; Vancomycin | 2019 |
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; Butyrates; Clostridiales; Colitis; Colon; Female; Gastrointestinal Microbiome; Gene Deletion; Humans; Inflammasomes; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-18; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NLR Proteins; Rectum; Signal Transduction; T-Lymphocytes; Vancomycin | 2018 |
Evaluation of Rectal Vancomycin Irrigation for Treatment of
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colitis; Female; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Survival Analysis; Therapeutic Irrigation; Treatment Outcome; Vancomycin | 2019 |
Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis.
Topics: Aged; Anti-Bacterial Agents; Colitis; Cytomegalovirus; Cytomegalovirus Infections; Drug Hypersensitivity Syndrome; Eosinophilia; Ganciclovir; Humans; Hypersensitivity, Delayed; Male; Nephritis, Interstitial; Vancomycin; Virus Activation | 2019 |
Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.
Topics: Animals; Cell Movement; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Epithelial Cells; Gram-Positive Bacteria; Humans; Inflammatory Bowel Diseases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, CCR2; Tumor Necrosis Factor-alpha; Vancomycin | 2015 |
Clostridium colitis: challenges in diagnosis and treatment.
Topics: ADP Ribose Transferases; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Colitis; Combined Modality Therapy; Disease Management; Female; Humans; Ileostomy; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2017 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss | 2015 |
Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
Topics: Animals; Anti-Bacterial Agents; Colitis; Drug Compounding; Drug Delivery Systems; Drug Liberation; Excipients; Feasibility Studies; Hydrogen-Ion Concentration; Male; Polymethacrylic Acids; Probiotics; Rabbits; Rats; Saccharomyces boulardii; Solubility; Vancomycin | 2016 |
Vancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils.
Topics: Animals; Azoxymethane; Bacteria; Colitis; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Humans; Mice; Neutrophils; Vancomycin | 2016 |
Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells.
Topics: Animals; Colitis; Colon; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Immunity, Innate; Interleukin-22; Interleukin-23; Interleukins; Intestinal Mucosa; Lymphocytes; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; STAT3 Transcription Factor; Vancomycin | 2017 |
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Male; Medical Records; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
Methicillin-resistant Staphylococcus aureus (MRSA) colitis--is there a problem?
Topics: Anti-Bacterial Agents; Colitis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2012 |
Clostridium difficile, vancomycin, and enterococcus.
Topics: Clostridioides difficile; Colitis; Contraindications; Enterococcus; Humans; Vancomycin | 1995 |
Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Colitis; Female; Interleukin-4; Lactobacillus; Limosilactobacillus reuteri; Meropenem; Mice; Mice, Inbred BALB C; Mice, SCID; Probiotics; Rectum; Thienamycins; Vancomycin; Water Supply | 2005 |
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; C-Reactive Protein; Clostridioides difficile; Colitis; Diarrhea; Humans; Hypoalbuminemia; Immunoglobulins, Intravenous; Leukocyte Count; Metronidazole; Middle Aged; Proteins; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Vancomycin | 2006 |
Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
Topics: Absorption; Aged; Anti-Bacterial Agents; Colitis; Enterocolitis, Pseudomembranous; Female; Humans; Kidney; Vancomycin | 2006 |
Cefotaxime-associated diarrhea and Clostridium difficile.
Topics: Arthritis, Rheumatoid; Cefotaxime; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Middle Aged; Prednisolone; Pulmonary Fibrosis; Vancomycin | 1984 |
Clostridium difficile colitis associated with the use of antineoplastic agents.
Topics: Adult; Aged; Antineoplastic Agents; Clostridium; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Male; Methotrexate; Middle Aged; Vancomycin | 1984 |
Absorption of vancomycin.
Topics: Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Intestinal Absorption; Male; Middle Aged; Vancomycin | 1984 |
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Colitis; Cytotoxins; Feces; Female; Humans; Male; Middle Aged; Vancomycin | 1983 |
Clostridium difficile colitis associated with cancer chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Neoplasms; Clostridium Infections; Colitis; Colonic Neoplasms; Diarrhea; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Vancomycin | 1982 |
Diarrhea we can treat: antibiotic-associated colitis.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1982 |
International recognition of methicillin-resistant strains of Staphylococcus aureus.
Topics: Australia; Colitis; Europe; Humans; Methicillin; Penicillin Resistance; Staphylococcus aureus; United States; Vancomycin | 1982 |
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters.
Topics: Animals; Clostridium; Clostridium Infections; Colitis; Cricetinae; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Mesocricetus; Vancomycin | 1981 |
Antimicrobial agent-associated colitis and diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Colitis; Cricetinae; Diarrhea; Humans; Infant; Infant, Newborn; Vancomycin | 1980 |
Antimicrobial agent-associated colitis and diarrhea.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Humans; Vancomycin | 1981 |
Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
Topics: Adolescent; Adult; Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Infant, Newborn; Male; Middle Aged; Recurrence; Vancomycin | 1981 |
Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
Topics: Clostridioides difficile; Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin | 1995 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; Interleukin-1; Metronidazole; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Vancomycin | 2001 |
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Colitis; Diet; Disease Models, Animal; Hordeum; Male; Metronidazole; Phytotherapy; Plant Preparations; Probiotics; Rats; Rats, Sprague-Dawley; Vancomycin | 2002 |
Partial purification of a toxin found in hamsters with antibiotic-associated colitis. Reversible binding of the toxin by cholestyramine.
Topics: Ammonium Sulfate; Animals; Antitoxins; Chemical Precipitation; Cholestyramine Resin; Chromatography, Gel; Clostridium; Colitis; Cricetinae; Cytotoxins; Feces; Gentamicins; HeLa Cells; Hydrogen-Ion Concentration; Lincomycin; Protein Binding; Trypsin; Ultracentrifugation; Ultrafiltration; Vancomycin | 1979 |
Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation.
Topics: Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Colitis; Culture Media; Feces; Humans; Hydrogen-Ion Concentration; Penicillins; Temperature; Vancomycin | 1979 |
Oral metronidazole in Clostridium difficile colitis.
Topics: Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin | 1979 |
Antibiotic-associated colitis--a bacterial disease.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Humans; Vancomycin | 1979 |
Antibiotic colitis--new cause, new treatment.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridium; Colitis; Colon; Feces; Humans; Vancomycin | 1979 |
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.
Topics: Animals; Autopsy; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Colitis; Colon; Diarrhea; DNA; Enterocolitis, Pseudomembranous; Ileitis; Intestinal Mucosa; Male; Rabbits; Vancomycin | 1978 |
[Comparative study of the therapeutic effect of the glycopeptide antibiotics eremomycin, vancomycin and ristomycin in a model of antibiotic-associated colitis in golden hamsters].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Colitis; Cricetinae; Disease Models, Animal; Female; Glycopeptides; Injections, Intraperitoneal; Lincomycin; Mesocricetus; Ristocetin; Vancomycin | 1992 |
Aminoglycosides and C. difficile colitis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Colitis; Humans; Vancomycin | 1990 |
Clostridium difficile toxin in chronic idiopathic colitis.
Topics: Adult; Bacterial Proteins; Bacterial Toxins; Chronic Disease; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Female; Humans; Male; Sulfasalazine; Vancomycin | 1986 |
Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium Infections; Colitis; Glycopeptides; Humans; Metronidazole; Teicoplanin; Vancomycin | 1987 |
Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Colitis; Cost Control; Humans; Metronidazole; Pharmacists; Pharmacy and Therapeutics Committee; Pharmacy Service, Hospital; Vancomycin | 1988 |
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin | 1987 |
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridium Infections; Colitis; Drug Evaluation; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Vancomycin | 1987 |
The significance of quantitative results of C. difficile cultures and toxin assays in patients with diarrhea.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Child; Child, Preschool; Clostridium; Colitis; Diarrhea; Feces; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Vancomycin | 1985 |
Antibiotic-associated colitis: why do patients relapse?
Topics: Bacitracin; Colitis; Humans; Metronidazole; Recurrence; Vancomycin | 1986 |